1. Corporate Officers - F
2. Fuglesang Christopher

Insider Trading History of Fuglesang Christopher

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Fuglesang Christopher since 2017. This trader's CIK number is 1465835. At the time of last reporting, Fuglesang Christopher was the Officer of Mirati Therapeutics, Inc.. (stock ticker symbol MRTX). Also see all insider trading activities at Mirati Therapeutics, Inc..

Note that in the past Fuglesang Christopher also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mirati Therapeutics, Inc. (MRTX) by Fuglesang Christopher

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	MRTX	2,517,946	$69,998,898	0	$0	0	$0
2021	MRTX	0	$0	400,005	$72,430,905	611,440	$611
2020	MRTX	0	$0	400,000	$80,800,000	400,003	$400
2017	MRTX	286,163	$1,602,512	0	$0	0	$0

Yearly summary of insider trading at Pandion Therapeutics, Inc. (PAND) by Fuglesang Christopher

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2020	PAND	722,222	$12,999,996	0	$0	0	$0

Insider trading activities at 2 companies by Fuglesang Christopher:

1. Mirati Therapeutics, Inc. (MRTX)

2. Pandion Therapeutics, Inc. (PAND)

Table 1. Insider trading of Mirati Therapeutics, Inc. (MRTX) by Fuglesang Christopher

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-08-11	MRTX	Buy	1,258,973	27.80	34,999,449
2023-08-11	MRTX	Buy	1,258,973	27.80	34,999,449
2021-03-05	MRTX	Sale	400,005	181.07	72,430,905
2021-03-05	MRTX	Option Ex	611,440	.00	611
2020-10-30	MRTX	Sale	400,000	202.00	80,800,000
2020-10-30	MRTX	Option Ex	400,003	.00	400
2017-01-06	MRTX	Buy	286,163	5.60	1,602,512

Table 2. Insider trading of Pandion Therapeutics, Inc. (PAND) by Fuglesang Christopher

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2020-07-21	PAND	Buy	722,222	18.00	12,999,996

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fuglesang Christopher (Officer of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month